February 7, 2007
IntraLase FS Laser Could Revolutionize Sight-Saving
Procedure of Last Resort for Patients; Potentially
Offers Better Safety and Visual Outcomes, Faster
Healing
TORONTO, Feb. 7 /CNW/ - A Toronto resident is
the first in Canada to have access to a revolutionary
new corneal transplant procedure - IntraLase-Enabled
Keratoplasty(TM) (IEK(TM)) - shown in clinical
studies to result in a potentially safer surgical
procedure, which may result in faster healing
and
better visual results for patients suffering from
severe corneal disease or damage.
"IEK is the greatest advancement we've had
in corneal transplantation in 50 years,"
says Corneal specialist, Dr. David Rootman, Associate
Professor of Ophthalmology, University of Toronto.
Dr. Rootman, who works out of the Yonge Eglinton
Laser Eye Centre, is the first surgeon in Canada
to perform IEK. "Preliminary clinical work
with IEK demonstrates that by creating incision
edges that fit together in an interlocking design,
the graft is more stable, and therefore may heal
faster," Dr. Rootman states.
The IntraLase(R) FS laser is the first laser to
creating complex shaped incisions that enable
recipient and transplant tissue to fit together,
much like an intricate puzzle. Incisions may be
customized to an individual patient's condition,
resulting in a potentially stronger graft that
may require fewer sutures, and enable faster healing
and visual recovery.Before the advent of the IEK
technology, corneal transplants were traditionally
performed using a hand-held, bladed "cookie
cutter" called a trephine, which was stamped
onto the cornea to make a circular incision with
straight, vertical edges. The transplanted tissue
graft required considerable suturing, and sutures
remained in the patient's eye for at least one
year, generally prohibiting full visual recovery
during that time. Conversely, fewer and/or looser
sutures are needed with the IEK technology and,
in initial cases, sutures were removed before
six months.
"It is gratifying to be involved with the
introduction of a new technology that has the
potential to revolutionize a surgical procedure,"
says Jay Herman, President of Sigmacon Medical
Products, Canadian distributor for IntraLase.
"Dr. Rootman and fellow surgeons from Toronto
Western Hospital have taken a pioneering step
in corneal transplant surgery."
More than 100 successful corneal transplant surgeries
have been performed since the first IEK corneal
transplant cases were announced in January 2006.
Data collected from 23 initial IEK cases demonstrated
significant improvement in vision over traditional
trephine-initiated corneal transplantation.
How it works
Instead of the straight vertical cut performed
in trephine-initiated corneal transplantation,
the IntraLase FS laser is programmed by the surgeon,
using IntraLase's patented computer interface,
to create precisely shaped incisions in both the
patient's diseased cornea and the transplant tissue.
Then, the laser's infrared light beam is precisely
focused to a point within the cornea where microscopic
bubbles are formed to establish the incision.
The laser is able to create complex incisions
that are nearly impossible for the manual, handheld
trephine.
For further information: Contact: Yonge Eglinton
Laser Eye Centre, David S. Rootman, MD, FRCSC,
(416) 603-5401, fax: (416) 603-1993; Sigmacon
Medical Products Corp., Terry O'Reilly, 1-800-898-7455
(x251)
|